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Abstract 
Review on OSGIN1, with data on DNA/RNA, on 
the protein encoded and where the gene is 
implicated. 
Identity 
Other names: BDGI, OKL38 
HGNC (Hugo): OSGIN1 
Location: 16q23.3 
DNA/RNA 
Note 
Human OSGIN1 is located on chromosome 16 in 
the region of q23.3. 
Description 
Human OSGIN1 gene is 13111 bp in length, 
composed of 6 exons and 5 introns, and located at 
chromosome 16q23.3. 
Transcription 
OSGIN1 transcript contains 6 exons. ORF is 1434 
bp, which expands from exon 2 to exon 6. And 
exon 6 also contributes to 371 bp 3'UTR. 
Protein 
Note 
Human OSGIN1/BDGI has a dominant isoform 
containing 477 amino acids with calculated 52 kDa 
molecular weight (derived from transcript variants 
HuOKL38-1a/2a).  
Besides, there are a 61 kDa longer isoform of 
OSGIN1 with 560 amino acids (transcribed from 
variant HuOKL38-2b), a 59 kDa longer isoform of 
OSGIN1 with 560 amino acids (transcribed from 
variant HuOKL38-2c), and a 34 kDa shorter 
isoform with 317 amino acids, which was the first 
one to identify in 2001 and might be generated by 
internal transcription start codon within ORF or 
cleaved from longer isoforms. 
 
 
OSGIN1 genomic organization and transcript. The schematic representation of human OSGIN1 gene and its transcript. ATG: 
translation start codon; TAA: translation stop codon; UTR: untranslated region; ORF: open reading frame (according to Ref-seq). 
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The predicted OSGIN1 structure contains a potential flavoprotein involved in K+ transport domain (TrkA) (201 aa), a potential 
NAD(P)-binding Rossmann-like domain (NAD_binding_8) (134 aa), a potential pyridine nucleotide-disulphide oxidoreductase 
domain (Pyr_redox_2) (201 aa) and a potential putative bacillithiol system oxidoreductase, YpdA family domain (Bthiol_YpdA) 
(295 aa). 
 
 
Description 
OSGIN1, described as a pregnancy-induced growth 
inhibitor, belongs to OKL38 protein family. 
Expression 
OSGIN1 gene was identified in rat mammary 
secretory epithelial cells, which was up-regulated 
significantly in mammary gland during pregnancy 
and lactation. In various human normal tissues, 
OSGIN1 transcripts are observed with basal levels, 
but increase remarkably in liver, followed by 
kidney, ovary, testis, and spleen especially. On the 
contrary, OSGIN1 show low or undetectable 
mRNA expression in liver, kidney, ovary tumor 
tissues compared to their paired normal 
counterparts. Similarly, it is rarely expressed in 
many cancer cell lines, including HepG2, SL, NIH, 
U2OS, MCF-7. 
Localisation 
Nucleus and mitochondria. 
Function 
OSGIN1 was first discovered in 2001 as a 
pregnancy-induced growth inhibitor. It is highly 
expressed in ovary, kidney and liver. Stable 
expression of OSGIN1 is characterized by 
relatively low proliferative rate and extensive 
differentiation. Conversely, loss of OKL38 activity 
leads to a disruption in the balance between cell 
growth, cell proliferation and cell death, and is 
associated with rapid tumor growth. OSGIN1 is 
inducible by distinct stress signals in multiple cell 
types. Oxidative stress induced by oxidized 
phospholipids (OxPAPC and its component lipid 
PEIPC) mediates expression of OSGIN1 regulated 
via Nox/Nrf2 pathway. After DNA damage 
treatment in cancer cells such as MCF-7 and U2OS,  
OSGIN1 is also up-regulated by p53, and then 
triggers apoptosis by changing mitochondrial 
morphology, elevating ROS levels and inducing 
cytochrome c release. Thus, OKL38 likely plays a 
critical role in multiple tissues to guard against 
tumorigenesis. 
Homology 
An alignment of the amino acid sequences in 
ClustalW showed that OSGIN1 and OSGIN2, 
another member of OKL38 family, share 49% 
sequence identity, especially in C-terminal region 
of the two proteins.  
However, the biological function of OSGIN2 
remains unclear so far, which may be implicated in 
Nijmegen breakage syndrome and gastric cancer. 
Mutations 
Somatic 
Based on analysis of tumor and adjacent 
noncancerous tissues from total 400 patients of 
hepatocellular carcinoma (HCC), a single-
nucleotide variation from G to A at nt 1494 of 
OSGIN1 was identified, resulting in an amino acid 
substitution R438H at codon region.  
Although OSGIN1 1494A variant appears in both 
tumor and noncancerous tissues, it shows higher 
occurrence in the tumor tissues than the common 
variant 1494G.  
And the allele-specific imbalance of OSGIN1 at 
nt1494 is highly possible due to its localization at 
chromosome 16q23.3, which is prone to loss of 
heterozygosity in a variety of cancers.  
Functional studies revealed that OSGIN1 1494A 
variant may have defects in translocation to 
mitochondria and apoptosis. 
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Implicated in 
Hepatocellular carcinoma (HCC) 
Disease 
HCC is the most common type of liver cancer and 
one of the top human malignances worldwide. 
Generally, chronic liver injury by cirrhosis and 
infection of hepatitis viruses are two major causes 
of HCC. HCC also show higher incidence in 
population of Asia/Africa than North 
America/Western Europe, suggesting a variety of 
underlying genetic and environmental factors. 
Prognosis 
OSGIN1 expression analysis between tumor and 
paired noncancerous tissues from 89 HCC patients 
with clinicopathological data indicated the patients 
with less OSGIN1 transcripts and higher occupancy 
of OSGIN1 1494A variant have more sever 
symptoms and shorter survival time. Thus, 
quantitation of OSGIN1 expression and presence of 
OSGIN1 1494A variant may help diagnose HCC 
patients at early clinical trail and their responses 
after chemotherapy. 
Oncogenesis 
OSGIN1 expression is higher in immortal liver cell 
lines (LO2 and Miha) that that in HCC cell lines 
(PLC8024 and Hep3B). Loss of wild-type OSGIN1 
in HCC tumors at higher stages and HCC cell lines 
may be due to its 5' untranslated region (5'UTR)-
regulated mRNA translation suppression. And 
OSGIN1 1494A variant coded protein is less 
capable to translocate from nucleus to mitochondria 
and induce apoptosis compared to its wide-type 
protein, suggesting its impaired role as tumor 
suppressor. 
Renal cell carcinoma (RCC) 
Disease 
Renal cell carcinoma (RCC) is the primary type of 
the adult kidney cancer. In contrast to HCC, RCC 
incidence rates are higher in North 
America/Western Europe region but lower in 
Asia/Africa region. The causes of RCC are 
complicated, probably due to lifestyle-related 
and/or hereditary factors. 
Prognosis 
Both OKL38 transcripts and protein levels are low 
or undetected in majority of the kidney tumors 
examined compared to patient's corresponding 
normal adjacent tissues using cancer profiling 
assay, western blot assay and immunohistological 
analysis. 
Oncogenesis 
Forced overexpression of OSGIN1 in human 
kidney cancer cell A498 inhibits cell growth and 
stimulates cell death. 
Breast cancer 
Disease 
Breast cancer is the most common cancer and the 
second top cause of cancer death among women. 
The American Cancer Society's estimates about 
232670 new cases of invasive breast cancer will be 
diagnosed in women in the US for 2014. Risk 
factors associated with breast cancer include age, 
geography, family history and so on. Especially, 
genetic risk factors with mutations in some 
signature genes (e.g. BRCA1 and BRCA2) have 
been studied well for prognosis and treatment of 
breast cancer. Interestingly, some particular 
reproductive factors like earlier age at first full-term 
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pregnancy and higher number of pregnancies can 
reduce breast cancer significantly. 
Oncogenesis 
Overexpression of OSGIN1 in MCF-7 human 
breast adenocarcinoma cells decreases their in vitro 
metastatic activity and in vivo tumor formation. 
The mechanistic study found that high expression 
of OSGIN1 may direct cell cycle arrested in S 
phase, and induce apoptosis further.  
These data suggest a potential correlation between 
OSGIN1 and the reduction in breast cancer risk 
observed in pregnancy-associated cases. 
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